{"disease":{"id":"sleepiness-due-to-obstructive-sleep-apnea","name":"Sleepiness Due To Obstructive Sleep Apnea","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"armodafinil","indication_name":"Sleepiness Due To Obstructive Sleep Apnea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nuvigil","generic_name":"ARMODAFINIL","company_name":"Nuvo Pharms","drug_phase":"marketed","molecular_target":"D(2) dopamine receptor","drug_class":"armodafinil","quality_score":54,"revenue":null,"mechanism":"Nuvigil works by selectively targeting the D(2) dopamine receptor to increase wakefulness and alertness."},{"drug_id":"modafinil","indication_name":"Sleepiness Due To Obstructive Sleep Apnea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Provigil","generic_name":"modafinil","company_name":"Nuvo Pharms","drug_phase":"marketed","molecular_target":"D(2) dopamine receptor","drug_class":"Sympathomimetic-like Agent [EPC]","quality_score":80,"revenue":null,"mechanism":"Provigil works by increasing the activity of certain neurotransmitters in the brain, such as dopamine, to help regulate sleep-wake cycles."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}